139 related articles for article (PubMed ID: 7983597)
1. First-pass metabolism of omeprazole in rats.
Watanabe K; Furuno K; Eto K; Oishi R; Gomita Y
J Pharm Sci; 1994 Aug; 83(8):1131-4. PubMed ID: 7983597
[TBL] [Abstract][Full Text] [Related]
2. Involvement of cytochrome P450 3A4 and P-glycoprotein in first-pass intestinal extraction of omeprazole in rabbits.
Fang HM; Xu JM; Mei Q; Diao L; Chen ML; Jin J; Xu XH
Acta Pharmacol Sin; 2009 Nov; 30(11):1566-72. PubMed ID: 19820718
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of DA-8159, a new erectogenic, after intravenous and oral administration to rats: hepatic and intestinal first-pass effects.
Shim HJ; Kim YC; Park KJ; Kim DS; Kwon JW; Kim WB; Lee MG
J Pharm Sci; 2003 Nov; 92(11):2185-95. PubMed ID: 14603504
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of diclofenac in rats intoxicated with CCL4, and in the regenerating liver.
Reyes-Gordillo K; Muriel P; Castañeda-Hernández G; Favari L
Biopharm Drug Dispos; 2007 Nov; 28(8):415-22. PubMed ID: 17828713
[TBL] [Abstract][Full Text] [Related]
5. First-pass metabolism of 5-fluorouracil in rats.
Yuasa H; Gu J; Hayashi Y; Watanabe J
J Pharm Pharmacol; 1998 Sep; 50(9):1019-25. PubMed ID: 9811163
[TBL] [Abstract][Full Text] [Related]
6. Dose-dependent pharmacokinetics of telithromycin after intravenous and oral administration to rats: contribution of intestinal first-pass effect to low bioavailability.
Lee JH; Lee MG
J Pharm Pharm Sci; 2007; 10(1):37-50. PubMed ID: 17498392
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of ipriflavone, an isoflavone derivative, after intravenous and oral administration to rats hepatic and intestinal first-pass effects.
Kim SH; Lee MG
Life Sci; 2002 Feb; 70(11):1299-315. PubMed ID: 11883708
[TBL] [Abstract][Full Text] [Related]
8. Dose-independent pharmacokinetics of a candidate for diabetic neuropathy, SR-4668, after intravenous and oral administration to rats: Intestinal first-pass effect.
Kim EJ; Bae SK; Kim HJ; Kim YG; Kim SO; Lee DH; Lim H; Lee MG
J Pharm Sci; 2003 May; 92(5):1112-24. PubMed ID: 12712431
[TBL] [Abstract][Full Text] [Related]
9. Gastrointestinal first-pass effect of YJA-20379-8, a new reversible proton pump inhibitor, in rats.
Kim J; Kim EJ; Han KS; Chang MS; Lee MG
J Pharm Pharmacol; 1999 Sep; 51(9):1031-6. PubMed ID: 10528986
[TBL] [Abstract][Full Text] [Related]
10. Dose-independent pharmacokinetics of metformin in rats: Hepatic and gastrointestinal first-pass effects.
Choi YH; Kim SG; Lee MG
J Pharm Sci; 2006 Nov; 95(11):2543-52. PubMed ID: 16937336
[TBL] [Abstract][Full Text] [Related]
11. Oral bioavailability of omeprazole before and after chronic therapy in patients with duodenal ulcer.
Ching MS; Mihaly GW; Angus PW; Morgan DJ; Devenish-Meares S; Yeomans ND; Smallwood RA
Br J Clin Pharmacol; 1991 Feb; 31(2):166-70. PubMed ID: 2049231
[TBL] [Abstract][Full Text] [Related]
12. Absolute oral bioavailability of traxoprodil in cytochrome P450 2D6 extensive and poor metabolisers.
Taylor TJ; Diringer K; Russell T; Venkatakrishnan K; Wilner K; Crownover PH; Benincosa LJ; Gibbs MA
Clin Pharmacokinet; 2006; 45(10):989-1001. PubMed ID: 16984212
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of oral and intravenous omeprazole in patients with the Zollinger-Ellison syndrome.
Vinayek R; Amantea MA; Maton PN; Frucht H; Gardner JD; Jensen RT
Gastroenterology; 1991 Jul; 101(1):138-47. PubMed ID: 2044903
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and first-pass elimination of metoprolol in rats: contribution of intestinal first-pass extraction to low bioavailability of metoprolol.
Yoon IS; Choi MK; Kim JS; Shim CK; Chung SJ; Kim DD
Xenobiotica; 2011 Mar; 41(3):243-51. PubMed ID: 21128757
[TBL] [Abstract][Full Text] [Related]
15. Dose-dependent pharmacokinetics of itraconazole after intravenous or oral administration to rats: intestinal first-pass effect.
Shin JH; Choi KY; Kim YC; Lee MG
Antimicrob Agents Chemother; 2004 May; 48(5):1756-62. PubMed ID: 15105131
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of various single intravenous and oral doses of omeprazole.
Andersson T; Cederberg C; Regårdh CG; Skånberg I
Eur J Clin Pharmacol; 1990; 39(2):195-7. PubMed ID: 2253676
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of sildenafil after intravenous and oral administration in rats: hepatic and intestinal first-pass effects.
Shin HS; Bae SK; Lee MG
Int J Pharm; 2006 Aug; 320(1-2):64-70. PubMed ID: 16730145
[TBL] [Abstract][Full Text] [Related]
18. Hepatic and intestinal first-pass effects of oltipraz in rats.
Bae SK; Kim JW; Kim YH; Kim YG; Kim SG; Lee MG
Biopharm Drug Dispos; 2005 May; 26(4):129-34. PubMed ID: 15744718
[TBL] [Abstract][Full Text] [Related]
19. Effect of soybean administration on the pharmacokinetics of carbamazepine and omeprazole in rats.
Singh D; Asad M
Fundam Clin Pharmacol; 2010 Jun; 24(3):351-5. PubMed ID: 19682087
[TBL] [Abstract][Full Text] [Related]
20. Study on the role of hepatic first-pass elimination in the low oral bioavailability of scutellarin in rats.
Hao X; Cheng G; Yu JE; He Y; An F; Sun J; Cui F
Pharmazie; 2005 Jun; 60(6):477-8. PubMed ID: 15997843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
